1. Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
   Xiaoting Zhou et al, 2023, Biomedicine & Pharmacotherapy CrossRef
2. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
   Morgane Lallier et al, 2021, Cells CrossRef
3. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63
   Xiong Shu et al, 2021, PeerJ CrossRef
4. Advances in the research of osteosarcoma stem cells and its related genes
   Weifei Zhang et al, 2022, Cell Biology International CrossRef
5. FOXO3a-dependent up-regulation of HSP90 alleviates cisplatin-induced apoptosis by activating FUNDC1-mediated mitophagy in hypoxic osteosarcoma cells
   Dian Lu et al, 2023, Cellular Signalling CrossRef
6. Recent Insights into Therapy Resistance in Osteosarcoma
   Zachary D. Prudowsky et al, 2020, Cancers CrossRef
7. Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma
   Zhao‐Peng Yao et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
8. A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
   Osama A. Mohammed et al, 2024, European Journal of Pharmaceutical Sciences CrossRef
9. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers
   Sara R. Martins-Neves et al, 2023, International Journal of Molecular Sciences CrossRef
10. Growth factors, cytokines, and pediatric malignant primary bones tumors
    Bénédicte Brounais Le-Royer et al, 2022, Bone Cancer CrossRef
11. Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG
    Mieun Lee-Theilen et al, 2021, Cells CrossRef
12. Hsp90: From Cellular to Organismal Proteostasis
    Milán Somogyvári et al, 2022, Cells CrossRef